Clinical Trials

GE HealthCare (Nasdaq: GEHC) announces the launch of CardioVisio for Atrial Fibrillation (AFib), a digital tool designed to assist clinicians in visualizing longitudinal data...

Researchers Found That Fluid Therapy Guided by Noninvasive, Continuous PVi Reduced Cardiopulmonary Complications and Fluid Administered Masimo (NASDAQ: MASI) announced the findings of a prospective, randomized...

Anuncia Medical has announced the successful first implant of the company’s US Food and Drug Administration (FDA)-cleared ReFlow mini flusher device. Performed on by neurosurgeon Samuel...

HAPPE Spine announces that the first clinical case with the INTEGRATE®-C Interbody Fusion System was completed by co-inventor and neurosurgeon Dr. Stephen Smith, MD, at the...

DermaSensor announced promising results from a sub-analysis study focusing on skin cancer detection across different skin tones. The sub-analysis came from the company’s DERM-SUCCESS study, which previously...

Clinicians at Royal Brompton Hospital, part of Guy’s and St Thomas’ NHS Foundation Trust, and St Bartholomew’s Hospital are the first in the UK...

Glucotrack (Nasdaq:GCK) announced that it completed a feasibility study for its implantable continuous glucose monitor (CGM). Rutherford, New Jersey-based Glucotrack designed its CGM for patients with...

Suono Bio Inc., the company revolutionizing therapeutic platforms to improve the efficacy and safety of novel medicines, has released encouraging results from the first...

White matter plays a critical role in brain function and reducing white matter atrophy and myelin loss may contribute to slowing Alzheimer’s disease progression. Early...